BIOVIE INC.
Nasdaq · CIK 0001580149 · Fiscal year end 0630
Latest reported period: Latest published period
Operating Income
$-16.9M
Net Income
$-5.3M
Eps Basic
-2.35
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-16.9M | - | - |
| Net Income | $-5.3M | - | - |
| Eps Basic | -2.35 | - | - |
| Eps Diluted | -2.35 | - | - |
| Cash And Equivalents | $13.1M | - | - |
| Total Assets | $17.5M | - | - |
| Total Liabilities | $1.9M | - | - |
| Shareholders Equity | $15.6M | - | - |
| Operating Cash Flow | $-14.9M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| S-1 | BIOVIE INC. | 2026-07-17 | 0001520138-26-000276 |
| 10-Q | BIOVIE INC. | 2026-05-11 | 0001520138-26-000154 |
| 10-Q | BIOVIE INC. | 2026-02-06 | 0001520138-26-000052 |
| 10-Q | BIOVIE INC. | 2025-11-10 | 0001520138-25-000343 |
| 10-K | BIOVIE INC. | 2025-08-15 | 0001520138-25-000268 |
| 4 | BIOVIE INC. | 2025-08-13 | 0001520138-25-000251 |